| Ramesh Madhavan, | |
|
6255 Inkster Rd Ste 101, Garden City, MI 48135-2538 | |
| (734) 458-4341 | |
| (248) 928-2275 |
| Full Name | Ramesh Madhavan |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 40 Years |
| Location | 6255 Inkster Rd Ste 101, Garden City, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205863867 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 4301077428 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Mercy Oakland | Pontiac, MI | Hospital |
| Garden City Hospital | Garden city, MI | Hospital |
| Lake Huron Medical Center | Port huron, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| International Medical Clinic Pllc | 0941626188 | 7 |
| Sjmh Medical Practice-smhc | 8628965175 | 37 |
News Archive
AVEO Pharmaceuticals, Inc. today announced the initiation of patient enrollment in an open-label, multicenter, randomized Phase 2 clinical trial, called BATON-CRC, evaluating tivozanib in combination with modified FOLFOX6 (mFOLFOX6) compared to bevacizumab in combination with mFOLFOX6 as first-line therapy in patients with advanced metastatic colorectal cancer.
Women who were either in the transition to menopause or postmenopausal experienced a reduction in the frequency and severity of menopausal hot flashes with the use of the antidepressant medication escitalopram, compared to women who received placebo, according to a study in the January 19 issue of JAMA.
BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company), today announced it has completed the acquisition of Cellular Research, Inc.
AVANIR Pharmaceuticals, Inc. today reported unaudited financial results for the three and twelve months ended September 30, 2009.
› Verified 1 days ago
| Entity Name | Sjmh Medical Practice-smhc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346284684 PECOS PAC ID: 8628965175 Enrollment ID: O20040301000770 |
News Archive
AVEO Pharmaceuticals, Inc. today announced the initiation of patient enrollment in an open-label, multicenter, randomized Phase 2 clinical trial, called BATON-CRC, evaluating tivozanib in combination with modified FOLFOX6 (mFOLFOX6) compared to bevacizumab in combination with mFOLFOX6 as first-line therapy in patients with advanced metastatic colorectal cancer.
Women who were either in the transition to menopause or postmenopausal experienced a reduction in the frequency and severity of menopausal hot flashes with the use of the antidepressant medication escitalopram, compared to women who received placebo, according to a study in the January 19 issue of JAMA.
BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company), today announced it has completed the acquisition of Cellular Research, Inc.
AVANIR Pharmaceuticals, Inc. today reported unaudited financial results for the three and twelve months ended September 30, 2009.
› Verified 1 days ago
| Entity Name | International Medical Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306473418 PECOS PAC ID: 0941626188 Enrollment ID: O20200818002534 |
News Archive
AVEO Pharmaceuticals, Inc. today announced the initiation of patient enrollment in an open-label, multicenter, randomized Phase 2 clinical trial, called BATON-CRC, evaluating tivozanib in combination with modified FOLFOX6 (mFOLFOX6) compared to bevacizumab in combination with mFOLFOX6 as first-line therapy in patients with advanced metastatic colorectal cancer.
Women who were either in the transition to menopause or postmenopausal experienced a reduction in the frequency and severity of menopausal hot flashes with the use of the antidepressant medication escitalopram, compared to women who received placebo, according to a study in the January 19 issue of JAMA.
BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company), today announced it has completed the acquisition of Cellular Research, Inc.
AVANIR Pharmaceuticals, Inc. today reported unaudited financial results for the three and twelve months ended September 30, 2009.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ramesh Madhavan, 6255 Inkster Rd Ste 101, Garden City, MI 48135-2538 Ph: (734) 458-4341 | Ramesh Madhavan, 6255 Inkster Rd Ste 101, Garden City, MI 48135-2538 Ph: (734) 458-4341 |
News Archive
AVEO Pharmaceuticals, Inc. today announced the initiation of patient enrollment in an open-label, multicenter, randomized Phase 2 clinical trial, called BATON-CRC, evaluating tivozanib in combination with modified FOLFOX6 (mFOLFOX6) compared to bevacizumab in combination with mFOLFOX6 as first-line therapy in patients with advanced metastatic colorectal cancer.
Women who were either in the transition to menopause or postmenopausal experienced a reduction in the frequency and severity of menopausal hot flashes with the use of the antidepressant medication escitalopram, compared to women who received placebo, according to a study in the January 19 issue of JAMA.
BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company), today announced it has completed the acquisition of Cellular Research, Inc.
AVANIR Pharmaceuticals, Inc. today reported unaudited financial results for the three and twelve months ended September 30, 2009.
› Verified 1 days ago
Dr. Nicholas Phillip Zendler, D.O Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6245 Inkster Rd, Garden City, MI 48135 Phone: 734-458-7205 | |
Dr. Andrew James Zillgitt, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6245 Inkster Rd, Garden City, MI 48135 Phone: 734-458-4486 | |
Ismail Rahal, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 6245 Inkster Rd, Garden City, MI 48135 Phone: 734-458-4486 | |
Dr. Alexander Rodrigo Tobar, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 6255 Inkster Rd Ste 101, Garden City, MI 48135 Phone: 248-955-9949 | |
Dr. Nathan Kumar, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 6245 Inkster Rd, Garden City, MI 48135 Phone: 248-895-1839 | |
Nihal Saran, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1061 Inkster Rd, Garden City, MI 48135 Phone: 734-291-0005 Fax: 313-281-2235 |